drugset / Trial / NCT05734716
Colorado-Oregon Altitude Study
RandomizedParallel-groupTriple-blindBasic science
Summary
Investigating the utility of prophylactic treatment with iron sucrose and/or erythropoietin on the prevention of acute mountain sickness in fit, young, healthy individuals.
Timeline
- Start
- 2021-02-17
- Primary completion
- 2022-08-01
- Completion
- 2023-01-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Iron sucrose | Unknown | 200 mg | Intravenous |
| Subject | epoetin alfa | Protein / enzyme biologic | 50 iu/kg | Subcutaneous |